- Home
- MBWM vs IRMD Comparison
MBWM vs IRMD Comparison
Compare MBWM & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MBWM | IRMD |
|---|---|---|
| Founded | 1997 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 862.3M | 1.3B |
| IPO Year | 1997 | 2014 |
Fundamental Metrics
Financial Performance| Metric | MBWM | IRMD |
|---|---|---|
| Price | $50.40 | $101.30 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $53.63 | N/A |
| AVG Volume (30 Days) | ★ 81.8K | 48.5K |
| Earning Date | 04-21-2026 | 05-08-2026 |
| Dividend Yield | ★ 3.13% | 0.80% |
| EPS Growth | 10.95 | ★ 16.67 |
| EPS | ★ 5.47 | 1.75 |
| Revenue | N/A | ★ $83,814,000.00 |
| Revenue This Year | $20.28 | $11.99 |
| Revenue Next Year | $4.67 | $9.91 |
| P/E Ratio | ★ $9.13 | $56.97 |
| Revenue Growth | N/A | ★ 14.43 |
| 52 Week Low | $37.76 | $47.48 |
| 52 Week High | $55.77 | $107.90 |
Technical Indicators
Market Signals| Indicator | MBWM | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 39.54 | 52.14 |
| Support Level | $49.95 | $97.37 |
| Resistance Level | $50.36 | $106.61 |
| Average True Range (ATR) | 1.63 | 3.22 |
| MACD | -0.34 | -0.28 |
| Stochastic Oscillator | 29.20 | 43.55 |
Price Performance
Historical ComparisonAbout MBWM Mercantile Bank Corporation
Mercantile Bank Corp operates as a bank holding company. It offers various commercial banking services to individuals, businesses, governmental units, and other institutions. These services include deposit products such as checking, savings, and term certificate accounts and lending products such as commercial, residential mortgage, and installment loans. The company generates revenue from interest and dividends earned on loans, securities, and other financial instruments.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.